Background

Methods

• Sepsis is a severe and life-threatening
condition that results from systemic
immune dysregulation
• miR-93-5p is upregulated in early-stage
sepsis and is proposed as a potential
targeted therapeutic

Aims
• The luciferase assay can be used to
evaluate miRNA binding by comparing
florescence levels between miRNA
knockouts and controls

Hypothesis
• We cloned a complementary miR-93-5p
sponge construct for use with the
luciferase assay in evaluating small
molecule inhibitors of miR-93-5p
function
• We also cloned luciferase constructs
containing predicted miR-93-5p binding
sites present on the CD28 gene to
evaluate miRNA binding

Results
A.

1bsmiR-93XhoPmeS/AS
5’-TCGAGTAGAGCTCTAGTCTACCTGCACGAACAGCACTTTGGTTT-3’
3’CATCTCGAGATCAGATGGACGTGCTTGTCGTGAAACCAAA-5’

Conclusions
A.

• Pilot results suggest that the luciferase assay can be used with Jurkat
suspension cells, however there are low levels of transfection across all
cell lines which require optimization

• As expected, the Jurkat miR-93-5p knockout expressed lower levels of
firefly luciferase activity compared to the wild-type and control lines

B.

• Preliminary results suggest that the luciferase assay can be used to
evaluate miR-93-5p binding using luciferase constructs, however
additional studies are required to confirm and optimize the efficacy

Future Work
• Optimization of the transfection process using electroporation,
lipofection, or a combination of the two

B.

• Following colony PCR validation of the presence of the CD28 insert
post ligation, the CD28 constructs will be sent for DNA sequencing and
eventual transfection into the Jurkat cell lines
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Fig 1. Construct and Subcloning Design
A) Complementary miR-93-5p sponge construct
B) Schematic of the subcloning procedure for CD28 binding site inserts into the luciferase vector

Fig 2. Dual Luciferase Reporter Assay Results Post-Transfection with the miR-93-5p Sponge
A) Renilla/Firefly luciferase values across Jurkat cell lines. (n=3, SEM shown)
B) Average doubling time of Jurkat cells over several passages (n=6)
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